Maulana, Basir W.

HRN: 25-23-86  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/12/2025
CEFTAZIDIME 1GM (VIAL)
06/12/2025
06/19/2025
IV
2g
Q24
Pulmonary Fibrosis To R/o PTB Retreatment After Lost To Follow Up
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  PneumoniaReproductive TractProphylaxis    Compliance to guidelines: